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Trajectories of total and central adiposity throughout
adolescence and cardiometabolic factors in early adulthood
J Araújo1,2, H Barros1,3, E Ramos1,3 and L Li2
BACKGROUND/OBJECTIVES: Our aim was to identify trajectories of total and central adiposity from 13 to 21 years, and to
investigate how adiposity changes at different phases of adolescence relate to adulthood cardiovascular risk factors.
SUBJECTS/METHODS: This study included participants from a population-based cohort (EPITeen), Portugal. Body mass index (BMI)
and waist circumference (WC) were measured at 13, 17 and 21 years, and sex- and age-speciﬁc z-scores were calculated. Adiposity
trajectories were identiﬁed using mixture growth models (BMI, n= 2901; WC, n = 2898). Cardiovascular risk factors were evaluated at
21 years (n = 1763): systolic (SBP) and diastolic blood pressure (DBP), insulin resistance (HOMA-IR), triglycerides and cholesterol.
Association of trajectory, and changes in adiposity z-scores with each cardiovascular risk factor was estimated by linear regression
models.
RESULTS: ‘Normal’, ‘high, declining’ and ‘high, increasing’ trajectories were identiﬁed in both sexes. ‘High, increasing’ BMI trajectory
was associated with less favorable cardiovascular risk proﬁle at 21 years in both sexes, whereas ‘high, declining’ presented a more
favorable proﬁle, similar to ‘normal’ trajectory in females. In addition, BMI increases between 13–17 years and 17–21 years were
associated with increases in systolic and diastolic blood pressure, and insulin resistance, but more strongly for the later period. For
every standard deviation (s.d.) increase in BMI between 17–21 years, mean SBP increased by 1.99 mmHg (95% conﬁdence interval
(CI): 1.01; 2.97) for females and 3.83 mmHg (2.67; 4.98) for males; the respective increase was 1.56 mmHg (0.72; 2.40) and
2.80 mmHg (1.97; 3.64) for DBP and 0.27 (0.21; 0.32) and 0.30 (0.24; 0.36) for HOMA-IR (log-transformed). Similar results were found
for WC.
CONCLUSIONS: Increases in adiposity, particularly from late adolescence-to-young adulthood, were associated with unfavorable
cardiovascular proﬁle in early adulthood. A beneﬁt on the cardiovascular risk proﬁle for participants in the declining adiposity
trajectory was observed.
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INTRODUCTION
The prevalence of obesity has risen rapidly in the recent decades
in most western populations.1 High adiposity is one of main
determinants of cardiovascular (CV) disease and its role as a CV
risk factor starts early in life. It has also been implicated in the
development of other CV risk factors.2 Therefore, the study of how
changes in adiposity across the life span inﬂuence the unfavorable
progression of the CV risk factors is important to understand their
impact on the disease development.
The study of growth trajectories in pediatric age is recognized
to be of great relevance for surveillance, etiology and clinical
practice,3 being useful for the identiﬁcation of critical windows for
intervention. A systematic review has shown a moderate tracking
of childhood overweight status into adulthood.4 There is also
evidence indicating substantial variations in individual growth
trajectories.5–7 Some studies identiﬁed distinct groups of trajec-
tories over the life course, which might impact differently on the
risk of disease.5,8–11
Although growth characteristics from birth to adolescence
and its later association with CV risk factors are well
documented,8,9,11,12 the impact of changes in adiposity from
adolescence-to-young adulthood is less well described. Yet this
period is recognized as critical for weight gain13,14 and subject to
important biological changes (for example, puberty).15
Research to estimate the relative contribution of fatness and fat
gain at different life stages on adult CV risk factors tends to focus
mainly on increases in adiposity in childhood16,17 and
adulthood.18 Some studies have reported that changes in body
mass index (BMI) early in life were of greater relevance for future
atherosclerosis19 or metabolic disturbances.20,21 Also, changes in
weight or BMI during adolescence or later in life are strongly
associated to adult blood pressure and metabolic
abnormalities.22–24 However, the periods assessed were different
which may limit comparisons between studies, and limited
evidence is available for the changes in other adiposity measures.
Therefore, this study aims: (i) to identify distinct trajectories of
total and central adiposity from adolescence (13 years) to early
adulthood (21 years); (ii) to investigate how adiposity changes at
particular age periods (13–17 or 17–21 years) are associated with
CV risk factors at early adulthood.
SUBJECTS AND METHODS
Study sample
This study included participants from the Epidemiological Health
Investigation of Teenagers in Porto (EPITeen)—a population-based cohort
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that recruited 13-year-old adolescents.25 Eligible participants were
adolescents born in 1990, attending schools of Porto, Portugal, during
2003–2004. Second and third study waves took place when participants
were on average 17 years (2007–2008) and 21 years of age (2011–2013).
We conducted our study in compliance with the principles of
Declaration of Helsinki. The research protocol was approved by the Ethic
Committee of Hospital S João and the Ethics Committee of the Institute of
Public Health from the University of Porto. In the ﬁrst and second study
waves, a signed informed consent was required for adolescents and
parents (or legal guardians), and only for participants in the third
study wave.
At the recruitment, 2159 eligible adolescents agreed to participate
(77.5% participation). In the second wave, we re-evaluated 1716
participants (79.5%), and a further 783 adolescents who moved to the
schools in Porto joined the cohort. Sixty percent (n= 1764) of the entire
cohort was re-evaluated in the third study wave.
Measures
Anthropometrics. Weight and height were measured with the subject in
light indoor clothes and no shoes, according to standardized procedures.
Waist circumference (to the nearest 0.1 cm) was measured midway
between the lower limit of the rib cage and the iliac crest, at the end of
gentle expiration, with a ﬂexible and non-distensible tape.
BMI and waist circumference (WC) z-scores were calculated by sex and
age for each study wave, using the mean and standard deviation of the
study sample.
Cardiovascular risk factors. For this analysis we considered CV risk factors
assessed at 21 years.
A blood sample was taken from an antecubital vein after an overnight
fast. An Olympus AU5400 automated clinical chemistry analyzer (Beckman-
Coulter, Brea, CA, USA) was used to measure glucose, total cholesterol,
high-density lipoprotein cholesterol (HDL) and triglycerides. Insulin was
measured by electro chemiluminescent immunoassay (Cobas e411
automated analyzer, Roche, Roche Diagnostics GmbH, Mannheim,
Germany). All determinations took place in the Department of Clinical
Pathology, Centro Hospitalar São João, Porto, Portugal.
The Friedewald equation26 was used to estimate low-density lipoprotein
cholesterol (LDL-C). The homeostatic model assessment (HOMA-IR) was
used as a marker of insulin resistance, calculated through the formula:
HOMA-IR= insulin (μU ml− 1) × glucose (mg dl− 1)/405.27
Blood pressure was measured using the oscillometric method (OMRON
Blood Pressure Monitor, M6 Comfort, OMRON Healthcare Co., Ltd., Kyoto,
Japan), according to standard procedures.28 A ﬁrst reading was taken after
10 min of rest, and a second one after at least 5 min. When the difference
between the ﬁrst two readings was higher than 5 mmHg, a third one was
taken. The average of the two closest measurements was used in this
analysis.
Covariates. Perinatal information was obtained through questionnaires
administered to the mothers at the baseline. When available, birth weight
was extracted from child health book records (n= 716); otherwise was
based on mother’s report. Maternal smoking was classiﬁed as: non-smoker;
smoker, but not during pregnancy; smoker during pregnancy.
Parental educational level was deﬁned according to the parent
presenting the highest education level. Parental occupational position
was categorized as ‘high’ (professional and managerial occupations),
‘medium’ (non-manual and manual skilled occupations) and ‘low’ (semi-
skilled and unskilled occupations). Self-reported weight and height of the
parents was used to calculate BMI, then converted to z-scores separately
for mother, father, and in each study wave. Parental BMI was deﬁned using
BMI z-score from the mother in study wave I, and if not available data from
wave II (24.1%); or when mother’s BMI was missing in both waves, from the
father (2.9%).
Separately for the mother and the father, family history of diabetes,
dyslipidemia and hypertension was collected, and for each of the diseases
classiﬁed as: positive, when the diagnosis was present for at least one of
the parents; negative, when none of the parents reported the diagnosis; or
non-classiﬁable, when the available information showed no diagnosis for
one of the parents, but missing regarding the other. The participant’s
practice of sports was deﬁned as any planned, regular exercise, regardless
of intensity and excluding obligatory curricular activities.
Statistical analysis
To identify trajectories of BMI and of WC from adolescence into adulthood
(aim 1), we applied mixture growth models, using the PROC TRAJ
procedure in SAS (v9.3, SAS Institute Inc., Cary, NC, USA).29 The models
were stratiﬁed by sex, and included a random intercept, a random linear
and a quadratic age term. We tested models up to six trajectory groups,
and the ﬁnal number of trajectories was chosen based on the lowest
Bayesian Information Criteria, and also by the interpretability of the results.
For each individual, the mixture growth model generated the probability
of belonging to each trajectory. Individuals were classiﬁed in the trajectory
to which they had the highest probability of belonging.
Analysis of the growth trajectories was based on participants with
adiposity measures at one or more ages (n= 2901 for BMI; n= 2898 for WC).
To investigate the association of adiposity levels and their changes at
different ages with CV risk factors in early adulthood (aim 2), we used sex-
speciﬁc z-scores of BMI and WC at each age so their associations with CV
risk factors can be compared across ages. A logarithmic transformation was
applied to triglycerides and HOMA-IR, as these variables were skewed.
First, we examined the associations of CV risk factors at 21 years with
adiposity measures at each age separately. The regression coefﬁcient
represents the change in CV risk factor for a s.d. increase in the adiposity
measure.
Second, the associations of changes in each adiposity measure
(a change in the ranking of the individual in the sample) between two
ages (13–17 and 17–21 years) with adult CV risk factors were examined.
Each model was conditioned on the adiposity measure at the previous age.
For example, to estimate the change in BMI z-score between 13 and 17
years of age on SBP at 21 years, we applied the regression model:
SBP21= a+b BMI13+c BMI17, which can be rewritten as SBP21= a+(b+c)
BMI13+c (BMI17–BMI13). The coefﬁcient c can be interpreted as the
estimated change in SBP associated with a s.d. increase in BMI between 13
and 17 years, given the BMI at 13 years.
All models were stratiﬁed by sex and further adjusted for birth weight,
mother’s smoking during pregnancy, parental education, household
occupational position, family history of disease, parental BMI z-score and
participant’s practice of sports. Regarding practice of sports, for associa-
tions with changes in adiposity between 13 and 17 years, we used sports at
13 years; for changes between 17 and 21 years, sports at 17 years.
We applied multiple imputation to the total cohort to use the maximum
information available. The imputation model included factors predicting
non-response (that is, sex, maternal/paternal education and occupation),
adiposity measures at all ages, CV risk factors at 21 years and all covariates
in the analysis models. We created 30 imputed datasets assuming missing
was at random given observed values of other variables. The regression
models and multiple imputation by chained equations were conducted
using SPSS (IBM Released 2013. IBM SPSS Statistics for Windows, Version
22.0. Armonk, NY, USA: IBM). In the regression models, we used imputed
covariates and adiposity measures, but not imputed outcomes, that is, we
restricted our analysis to individuals with observed CV risk factors (1763
participants with valid information for at least one cardiovascular risk
factor at 21 years). Parameters estimated were combined to obtain overall
estimates using Rubin’s rule.
RESULTS
Descriptive data on BMI and WC at each study wave and
cardiovascular risk factors at 21 years is presented in Table 1.
Trajectories of BMI/WC from adolescence into adulthood
Three trajectory groups of BMI were identiﬁed for each sex
(Figure 1): ‘normal’ (78.7% in females; 80.4% in males); ‘high,
increasing’ (17 and 6.4%); and ‘high, declining’ (4.2 and 13.1%).
‘Normal’ trajectory presented the lowest mean BMI values and low
prevalence of overweight at any of the three study waves
(Supplementary Table S1). At 13 years, subjects in trajectory ‘high,
increasing’ presented intermediate mean values of BMI, however
they increased more rapidly with age, and were the highest at 21
years (29.3% in females; 65.2% in males), compared with the other
trajectories. Trajectory ‘high, declining’ presented the highest
mean values of BMI at 13 years, but they decreased with age,
being the prevalence of obesity at 21 years 7.5 and 11.2% for
females and males, respectively (Supplementary Table S1).
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For waist circumference, three trajectories were also identiﬁed
(Figure 2) and they were graphically and in prevalence similar to
those identiﬁed for BMI. The agreement between the trajectories
identiﬁed based on BMI and on WC was strong (observed
agreement of 88 and 91.4%; kappa = 0.657 and 0.745, respectively,
for females and males). ‘Normal’ WC trajectory was found in
around 80% of the subjects in both sexes; ‘high, increasing’ in
17.9% of females and 8.4% of males; and trajectory ‘high,
declining’ in 2 and 11.6% of females and males, respectively
(Supplementary Table S2).
Table 2 relates CV risk factors at 21 years to the probability of
belonging to each trajectory. Considering the ‘normal’ trajectory
as the reference group, belonging to the ‘high, increasing’
trajectory was associated with higher SBP, HOMA-IR, triglycerides
and LDL, and decreased HDL at 21y in both sexes, but stronger in
males, except for HDL. For ‘high, declining’ trajectory, in females
there were no statistically signiﬁcant differences in CV risk factors,
compared with the ‘normal’ trajectory, except for HDL. In males,
higher probability of belonging to the ‘high, declining’ trajectory
was associated with higher mean SBP, DBP, HOMA-IR and
triglycerides, and lower HDL at 21 years, but the magnitude was
lower than for subjects belonging to the ‘high, increasing’
trajectory.
The associations for WC (Table 2) were in general similar to
those for BMI, but weaker.
Associations between changes in BMI/WC and CV risk factors
Adjusted models using multiple imputation showed that BMI
z-score at each age (13, 17 or 21 years) was positively associated
with SBP, DBP, HOMA-IR, triglycerides and LDL, and inversely
associated with HDL, in both sexes, and appeared to be stronger
in males (Table 3). Associations generally strengthened with
increasing age. Results for WC z-score were similar, but associa-
tions were slightly weaker (Table 3).
Changes in BMI z-score from 13 to 17 years and from 17 to 21
years were positively associated with SBP, DBP and HOMA-IR in
both sexes (Table 4). For example, in females for every s.d.
increase in BMI between 13 and 17 years, SBP increased on
average by 1.79 mmHg (95% CI 0.48; 3.10), whereas for
every s.d. increase between 17 and 21 years, SBP increased on
average by 1.99 mmHg (1.01; 2.97); for males associations
were stronger: 2.03 mmHg (0.47; 3.59) for BMI changes for
13-17 years, and 3.83 mmHg (2.67; 4.98) for 17–21 years. For
triglycerides and LDL, the association was stronger for 17–21 years
than 13–17 years. For HDL an inverse association was
found for the period 13–17 years in both sexes, and for 17–21
years only in males.
Similar results were found for WC z-score (Table 4): positive
associations between increases in WC and SBP, DBP, HOMA-IR,
triglycerides and LDL and negative associations with HDL.
Either for BMI or WC, regression coefﬁcients were in general
stronger in males and for the period 17 to 21 years.
Analyses were repeated using complete cases and as conclu-
sions were mostly unaltered, those results are presented only in
Supplementary Tables S3 and S4.
DISCUSSION
Main ﬁndings
Using our longitudinal population-based study we identiﬁed
three trajectories of total and central adiposity from
adolescence-to-adulthood. Although the majority (475%) of
individuals were in the normal trajectory group, the ‘high,
Table 1. Descriptive information on anthropometric measures and
cardiovascular risk factors in the EPITeen cohort, Porto, Portugal
Females Males P-valuea
n Mean (s.d.) n Mean (s.d.)
Anthropometric variables
BMI (kg m−2)
13 years 1053 21.1 (3.5) 984 20.7 (3.6) 0.003
17 years 1267 22.2 (3.4) 1202 22.5 (3.5) 0.048
21 years 903 22.6 (3.9) 854 23.6 (3.7) o0.001
Waist circumference (cm)
13 years 1045 71.8 (8.2) 981 73.3 (9.5) o0.001
17 years 1274 74.6 (8.2) 1203 78.4 (8.8) o0.001
21 years 896 73.8 (9.3) 853 81.7 (9.4) o0.001
CV risk factors at 21 years
SBP (mmHg) 903 102 (8.8) 853 115.9 (10.4) o0.001
DBP (mmHg) 903 68.1 (7.5) 853 69.6 (7.5) o0.001
HOMA-IR 864 1.86 (0.88) 806 1.74 (1) 0.014
Triglycerides (mg dl− 1) 877 94.1 (42.9) 810 77.5 (33.9) o0.001
LDL (mg dl− 1) 877 104.9 (27.8) 813 99.6 (25.9) o0.001
HDL (mg dl− 1) 878 62.2 (12.4) 813 49.7 (9.4) o0.001
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL,
high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assess-
ment; LDL, low-density lipoprotein cholesterol; SBP, systolic blood pressure;
s.d., standard deviation. aP-value from the Student t-test for the
sex-differences comparison.
Figure 1. Trajectories of body mass index from 13 to 21 years of age in females (left) and in males (right), in the EPITeen cohort, Porto,
Portugal.
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increasing’ trajectory (more frequently females) had a high BMI/
WC in adolescence and gained BMI/WC more rapidly, thereafter,
presenting the highest prevalence of obesity and the worst
proﬁle of CV risk factors at 21 years of age, particularly in males.
A small group (more frequently males) had a high BMI/WC in
early adolescence but it declined from adolescence-to-early
adulthood. Among ‘high, declining’ group, in females the CV risk
factors at 21 years did not differ from normal group, whereas for
males, although worse than those in the normal group, CV risk
factors were more favorable than those in the ‘high, increasing’.
In addition to the identiﬁcation of trajectories, we also found
that adiposity changes from 13 to 21 years were associated with
unfavorable values of the CV risk factors evaluated, and
excessive increases between 17 and 21 years of age (moving
up in relative position for BMI in the population) were
particularly inﬂuential. These results were similar using either
BMI or WC.
Strengths and limitations
Major strengths of this study include the use of both BMI and WC
and applying innovative modeling techniques for the identiﬁca-
tion of trajectories, allowing the study of the effect of cumulative
exposure to adiposity on CV risk factors, and not only the effect of
the adiposity in a speciﬁc age. In addition, in a period under
characterized—transition from adolescence-to-adulthood, our
study adds information on the speciﬁc effect of adiposity changes
at different ages. We used repeated measurements of adiposity
objectively measured under standardized procedures, as well as
repeated measurements of many confounders, from a population-
based cohort, enabling the generalizability of the results.
Nonetheless, potential limitations of the study exist. Losses to
follow-up and item non-response led to missing data. We
conducted analyses using multiple imputation for BMI, WC and
covariates including the main predictors of missing data, which
would have reduced selection bias. However, our ﬁnal models
Figure 2. Trajectories of waist circumference from 13 to 21 years of age in females (left) and in males (right), in the EPITeen cohort, Porto,
Portugal.
Table 2. Crude regression coefﬁcients for the association between probability of trajectory membership and cardiovascular risk factors at 21 years of
age in the EPITeen cohort, Porto, Portugal
Outcome 21 years Probability of BMI trajectory membership in femalesa Probability of BMI trajectory membership in malesa
High, increasing High, declining High, increasing High, declining
SBP 6.14 (4.34, 7.94) − 0.05 (−3.13, 3.03) 10.37 (7.46, 13.29) 2.48 (0.12, 4.84)
DBP 5.64 (4.10, 7.17) − 0.08 (−2.70, 2.54) 10.30 (8.25, 12.36) 2.34 (0.68, 4.00)
HOMA-IRb 0.58 (0.48, 0.68) − 0.06 (−0.23, 0.11) 0.94 (0.79, 1.08) 0.18 (0.06, 0.29)
TRIGb 0.12 (0.04, 0.21) 0.00 (−0.15, 0.15) 0.34 (0.22, 0.46) 0.12 (0.03, 0.21)
LDL 14.04 (8.26, 19.83) − 4.80 (−14.72, 5.12) 26.11 (18.67, 33.55) 1.22 (−4.73, 7.16)
HDL − 3.76 (−6.35, − 1.17) − 4.53 (−8.97, − 0.09) − 6.70 (−9.44, − 3.96) − 2.35 (−4.54, − 0.16)
Outcome 21 years Probability of WC trajectory membership in femalesa Probability of WC trajectory membership in malesa
High, increasing High, declining High, increasing High, declining
SBP 5.41 (3.62, 7.20) 0.34 (−4.00, 4.69) 9.32 (6.72, 11.92) 3.49 (0.96, 6.03)
DBP 4.90 (3.37, 6.43) − 1.29 (−4.99, 2.40) 9.60 (7.78, 11.43) 2.25 (0.46, 4.03)
HOMA-IRb 0.56 (0.46, 0.66) − 0.02 (−0.26, 0.21) 0.93 (0.80, 1.06) 0.26 (0.14, 0.39)
TRIGb 0.14 (0.06, 0.23) − 0.00 (−0.22, 0.21) 0.37 (0.27, 0.47) 0.10 (−0.00, 0.19)
LDL 12.31 (6.55, 18.07) − 4.37 (−18.20, 9.45) 22.50 (15.87, 29.12) 1.15 (−5.37, 7.67)
HDL − 5.56 (−8.12, − 2.99) − 3.49 (−9.64, 2.67) − 5.67 (−8.11, − 3.23) − 1.82 (−4.22, 0.58)
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment; LDL,
low-density lipoprotein cholesterol; SBP, systolic blood pressure; TRIG, triglycerides; WC, waist circumference. aTrajectory ‘normal’ is the reference group.
bResults are presented for the log-transformed variable.
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were ﬁtted only to participants with measured outcomes in the
third study wave. Attrition in the third wave was higher among
participants with lower parental education, and among those
obese at the recruitment age. The underrepresentation of obese
participants may have led to an underestimation of the
associations reported in our study.
Interpretation of ﬁndings
Information on growth trajectories in the period from
adolescence-to-adulthood is limited. To our knowledge, ﬁve
studies have identiﬁed BMI trajectories in this age period using
similar methodology11,30–33 and found three to four distinct
trajectories, with some groups being similar to the trajectories
‘normal’ and ‘high, increasing’ identiﬁed in our study. A declining
trajectory was only identiﬁed in two of these studies.11,32 Ziyab
et al.11 using data from infancy to 18 years, identiﬁed an ‘early
transient overweight’ trajectory. However, this trajectory was
characterized by a decline in BMI z-score from 1 to 10 years of age,
and a stabilization from 10 to 18 years, whereas the declining
trajectory in our study presented declining values of BMI more
Table 3. Adjusted regression coefﬁcients (mean change) for cardiovascular risk factors at 21 years of age per standard deviation increase in BMI and
in WC at different ages (13, 17 and 21 years) in the EPITeen cohort, Porto, Portugal—missing covariates imputed (m= 30 imputations)
Outcome 21 years Exposure (years) Females Males
BMI z-score WC z-score BMI z-score WC z-score
SBP 13 1.45 (0.78, 2.12) 1.25 (0.56, 1.94) 2.11 (1.31, 2.90) 1.99 (1.21, 2.78)
17 1.78 (1.14, 2.41) 1.40 (0.76, 2.03) 2.31 (1.57, 3.05) 2.30 (1.57, 3.03)
21 2.08 (1.49, 2.67) 1.82 (1.22, 2.40) 3.27 (2.59, 3.96) 3.19 (2.50, 3.87)
DBP 13 1.06 (0.50, 1.61) 0.88 (0.30, 1.46) 1.68 (1.13, 2.24) 1.58 (1.03, 2.13)
17 1.42 (0.88, 1.96) 1.30 (0.76, 1.84) 1.88 (1.35, 2.41) 1.76 (1.24, 2.29)
21 1.65 (1.14, 2.15) 1.43 (0.93, 1.93) 2.45 (1.95, 2.94) 2.50 (2.01, 3.00)
HOMA-IRa 13 0.09 (0.05, 0.13) 0.09 (0.05, 0.13) 0.17 (0.12, 0.21) 0.16 (0.12, 0.21)
17 0.11 (0.07, 0.14) 0.10 (0.06, 0.14) 0.18 (0.14, 0.22) 0.19 (0.15, 0.23)
21 0.18 (0.15, 0.22) 0.19 (0.15, 0.22) 0.25 (0.21, 0.28) 0.26 (0.22, 0.29)
TRIGa 13 0.02 (−0.01, 0.05) 0.04 (0.00, 0.07) 0.08 (0.05, 0.11) 0.08 (0.05, 0.11)
17 0.01 (−0.02, 0.04) 0.03 (0.00, 0.06) 0.08 (0.05, 0.11) 0.09 (0.06, 0.12)
21 0.05 (0.02, 0.08) 0.06 (0.03, 0.09) 0.10 (0.07, 0.13) 0.11 (0.08, 0.14)
LDL 13 1.40 (−0.72, 3.53) 0.34 (−1.83, 2.52) 4.06 (2.06, 6.05) 2.79 (0.78, 4.80)
17 2.50 (0.47, 4.53) 1.97 (−0.05, 3.99) 4.26 (2.34, 6.17) 3.04 (1.15, 4.93)
21 4.19 (2.29, 6.08) 3.25 (1.36, 5.14) 6.76 (4.54, 8.12) 5.67 (3.89, 7.45)
HDL 13 − 1.22 (−2.16, − 0.28) − 1.49 (−2.44, − 0.53) − 1.38 (−2.11, − 0.64) − 1.23 (−1.99, − 0.47)
17 − 1.49 (−2.39, − 0.59) − 1.68 (-2.58, − 0.79) − 1.73 (−2.44, − 1.03) − 1.50 (−2.19, − 0.81)
21 − 1.16 (−2.01, − 0.31) − 1.58 (-2.42, − 0.74) − 2.02 (−2.68, − 1.36) − 1.78 (−2.44, − 1.12)
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment; LDL,
low-density lipoprotein cholesterol; SBP, systolic blood pressure; TRIG: triglycerides; WC: waist circumference. aResults are presented for the log-transformed
variable. N ranges between 864 and 903 for females, and 806 and 853 for males, depending on the outcome. Estimates were adjusted for birth weight;
mother’s smoking during pregnancy; parental education; household occupational position; family history of hypertension, diabetes or dyslipidaemia
(according to the outcome); parental BMI z-score; and participant’s practice of sports.
Table 4. Adjusted regression coefﬁcients for cardiovascular risk factors at 21 years of age per standard deviation increase in BMI and in WC during
different periods (13–17 years; 17–21 years) in the EPITeen cohort, Porto, Portugal—missing covariates imputed (m= 30 imputations)
Outcome 21 years Exposure (years) Females Males
BMI z-score WC z-score BMI z-score WC z-score
SBP 13–17 1.79 (0.48, 3.10) 1.05 (0.10, 1.99) 2.03 (0.47, 3.59) 1.97 (0.70, 3.23)
17–21 1.99 (1.01, 2.97) 1.67 (0.85, 2.48) 3.83 (2.67, 4.98) 3.01 (1.99, 4.03)
DBP 13–17 1.72 (0.63, 2.80) 1.36 (0.57, 2.14) 1.58 (0.50, 2.66) 1.41 (0.53, 2.29)
17–21 1.56 (0.72, 2.40) 1.07 (0.37, 1.76) 2.80 (1.97, 3.64) 2.70 (1.97, 3.44)
HOMA-IRa 13–17 0.10 (0.03, 0.18) 0.08 (0.02, 0.13) 0.15 (0.07, 0.23) 0.16 (0.09, 0.22)
17–21 0.27 (0.21, 0.32) 0.22 (0.18, 0.27) 0.30 (0.24, 0.36) 0.27 (0.22, 0.33)
TRIGa 13–17 − 0.01 (−0.07, 0.05) 0.01 (−0.03, 0.06) 0.04 (−0.02, 0.10) 0.07 (0.02, 0.12)
17–21 0.12 (0.07, 0.16) 0.07 (0.03, 0.11) 0.10 (0.05, 0.15) 0.11 (0.07, 0.15)
LDL 13–17 4.29 (0.25, 8.33) 3.39 (0.39, 6.39) 2.81 (−1.06, 6.68) 2.34 (− 0.87, 5.54)
17–21 6.16 (2.99, 9.34) 3.72 (1.11, 6.33) 8.62 (5.63, 11.62) 7.98 (5.33, 10.64)
HDL 13–17 − 1.54 (−3.33, 0.26) − 1.36 (−2.67, − 0.04) − 1.92 (−3.34, − 0.50) − 1.44 (−2.66, − 0.23)
17–21 − 0.10 (−1.50, 1.30) − 0.94 (−2.10, 0.21) − 1.92 (−3.04, − 0.80) − 1.68 (−3.33, −0.69)
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment; LDL,
low-density lipoprotein cholesterol; SBP, systolic blood pressure; TRIG, triglycerides; WC, waist circumference. aResults are presented for the log-transformed
variable. N ranges between 864 and 903 for females, and 806 and 853 for males, depending on the outcome. Estimates were adjusted for birth weight;
mother’s smoking during pregnancy; parental education; household occupational position; family history of hypertension, diabetes or dyslipidaemia
(according to the outcome); parental BMI z-score; and participant’s practice of sports.
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pronounced from 17 to 21 years of age, than from 13 to 17 years.
In Canada’s National Longitudinal Survey of Children and Youth32
a decreasing trajectory was also identiﬁed from age 1 to 20 years
and the decrease in BMI values was more evident in females, as
we also found in our study, although it occurred at earlier ages in
their study—from early to mid-adolescence. The small sample size
of the group ‘high, declining’ identiﬁed in our sample, particularly
in females, limited our ability to explore in depth the character-
istics of this group.
‘High, increasing’ trajectory presented the worst levels of CV risk
factors at 21 years of age, whereas the levels in the ‘high,
declining’ trajectory were closer to those in the ‘normal’ group.
This ﬁnding is also in accordance to other study that found higher
systolic and diastolic blood pressure at 18 years in the delayed
overweight trajectory in comparison to the ‘normal’ trajectory, but
still smaller than the values found for the early persistent obesity
trajectory.11 Regarding studies in other age ranges, in the Raine
Study,7 those in increasing trajectories from birth to 14 years
presented the highest insulin resistance levels at 14 years,
whereas the outcome in those from declining trajectories was
similar to those in the reference trajectory (‘Optimal growth’). Girls
in the ‘upward percentile crossing’ trajectory from 5 to 15 years
had highest metabolic risk factors at 15 years, whereas the
‘delayed downward percentile crossing’ presented similar levels in
comparison to the ‘50th percentile tracking’.9 These results and
those from our study suggest that excessive gains in adiposity
during the pediatric ages are associated with adverse CV risk
factors, partly because it is likely to result in high current BMI. This
is supported by the sex-differences in the association between
‘high, declining’ trajectory and the CV risk factors in our study. In
females there was a marked decrease in BMI between 13 and 21
years in this trajectory, but the ﬁnal BMI mean value was closer to
the mean BMI value in the ‘normal’ trajectory and this resulted in
no statistically signiﬁcant differences in the outcomes between
these two trajectories. In males, there was a small decline in BMI
mean values, but the difference in BMI values at 21 years in
comparison to the ‘normal’ trajectory was higher than in females,
resulting in increased values of CV risk factors at 21 years,
although of lower magnitude in comparison to the ‘high,
increasing’ group.
To our knowledge, this is the ﬁrst study addressing waist
circumference trajectories in the period from adolescence-to-
adulthood. Trajectories of WC were similar to the BMI
trajectories, and associations of WC trajectories with CV risk
factors at 21 years were of the same magnitude to those found
for BMI trajectories. Although WC is described as a measure of
central or abdominal adiposity, it is highly correlated to BMI
(correlations around 0.8 in females and 0.9 in males at each age,
in our study). Other studies have found that BMI and WC
perform similarly in the association with CV risk factors.34–36
We found that changes in adiposity, both from 13 to 17 years
and from 17 to 21 years, were associated to unfavorable CV risk
parameters at 21 years, but the magnitude was stronger for the
later period. These results suggest that changes in adiposity in
these speciﬁc ages (17 to 21 years) are more relevant for CV risk
factors. During early and mid-adolescence the effect of adiposity
changes in CV risk factors may be of lower magnitude, as other
factors such as hormonal changes related to puberty may also
inﬂuence lipid and insulin levels.37,38 The comparison of changes
in the speciﬁc periods evaluated here with other studies is difﬁcult
due to the differences in the periods evaluated, but two studies
using data from the 1958 British birth cohort, and evaluating
similar periods (11–16 years and 16–23 years) also found stronger
associations for the changes in BMI from 16 to 23 years with adult
glycosylated hemoglobin24 and blood pressure at 45 years.39
However, this could be because the period is closer in time to the
outcome, rather than an effect of this speciﬁc period (17–21 years)
under study, as described in other studies.22–24,39
In conclusion, our study identiﬁed three distinct trajectories of
BMI and WC from adolescence-to-adulthood, and showed a
beneﬁt on the cardiovascular risk proﬁle for those in the declining
adiposity trajectory. The similar results for the two adiposity
measures support that both BMI and WC are surrogates of
global adiposity. In addition, increases in BMI and WC, particularly
recent changes from late adolescence-to-young adulthood, had a
strong positive association with traditional cardiovascular risk
factors. Our results highlight the importance of promote a healthy
BMI at all ages to prevent unfavorable cardiovascular risk factors
and future disease.
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